Shares of DaVita Inc. /zigman2/quotes/204229673/composite DVA +0.93% slid 2.21% to $84.40 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.16% falling 1.03% to 3,655.04 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.08% falling 1.11% to 29,260.81. This was the stock's fifth consecutive day of losses. DaVita Inc. closed $40.41 short of its 52-week high ($124.81), which the company reached on April 20th.
The stock underperformed when compared to some of its competitors Monday, as Fresenius Medical Care AG & Co. KGaA ADR /zigman2/quotes/210057637/composite FMS +1.64% fell 1.60% to $14.16, Laboratory Corp. of America Holdings /zigman2/quotes/203174601/composite LH +0.61% fell 0.58% to $210.43, and Universal Health Services Inc. Cl B /zigman2/quotes/208539347/composite UHS -0.11% fell 2.03% to $89.89. Trading volume (509,564) remained 245,350 below its 50-day average volume of 754,914.